Business Description
Navidea Biopharmaceuticals Inc
NAICS : 325413
SIC : 2835
ISIN : US63937X1037
Description
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.07 | |||||
| Equity-to-Asset | -0.57 | |||||
| Debt-to-Equity | -0.39 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -99.89 | |||||
| Beneish M-Score | 2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.6 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | 22.6 | |||||
| 3-Year Book Growth Rate | -45.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.15 | |||||
| 9-Day RSI | 44.62 | |||||
| 14-Day RSI | 46.08 | |||||
| 6-1 Month Momentum % | -26.39 | |||||
| 12-1 Month Momentum % | -85.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.56 | |||||
| Quick Ratio | 0.51 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 2925.84 | |||||
| Days Sales Outstanding | 19199 | |||||
| Days Payable | 16223.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.3 | |||||
| Shareholder Yield % | -22.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -4900 | |||||
| Operating Margin % | -1017900 | |||||
| Net Margin % | -118200 | |||||
| FCF Margin % | -990700 | |||||
| ROA % | -21.96 | |||||
| ROIC % | -357.48 | |||||
| ROC (Joel Greenblatt) % | -5998.67 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.18 | |||||
| EV-to-EBITDA | -0.18 | |||||
| EV-to-Revenue | 1599 | |||||
| EV-to-FCF | -0.14 | |||||
| Earnings Yield (Greenblatt) % | -555.56 | |||||
| FCF Yield % | -282.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NAVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Navidea Biopharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.001 | ||
| EPS (TTM) ($) | -0.06 | ||
| Beta | 0.32 | ||
| Volatility % | 80.17 | ||
| 14-Day RSI | 46.08 | ||
| 14-Day ATR ($) | 0.010024 | ||
| 20-Day SMA ($) | 0.039363 | ||
| 12-1 Month Momentum % | -85.95 | ||
| 52-Week Range ($) | 0.021 - 0.276 | ||
| Shares Outstanding (Mil) | 100.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Navidea Biopharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Navidea Biopharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Navidea Biopharmaceuticals Inc Frequently Asked Questions
What is Navidea Biopharmaceuticals Inc(NAVB)'s stock price today?
The current price of NAVB is $0.04. The 52 week high of NAVB is $0.28 and 52 week low is $0.02.
When is next earnings date of Navidea Biopharmaceuticals Inc(NAVB)?
The next earnings date of Navidea Biopharmaceuticals Inc(NAVB) is 2024-06-07 Est..
Does Navidea Biopharmaceuticals Inc(NAVB) pay dividends? If so, how much?
Navidea Biopharmaceuticals Inc(NAVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers